Antiphospholipid Syndrome ( APS)
|
|
- Merilyn Pope
- 5 years ago
- Views:
Transcription
1 Antiphospholipid Syndrome ( APS) Edward John Walter Bowie, MD Mayo Medical School the first to identify APS as an acquired thrombophilia Graham Robert Vivian Hughes MD FRCP Unit Rayne Institute St Thomas Hospital UK the first to identify APS as a generalized autoimmune disorder Hassouna February 2,
2 Several investigators reported prolonged clotting times that do not correct in mixing of SLE patient plasma with normal plasma. They named the substance Circulating Anticoagulant, Acquired Inhibitor, Lupus Anticoagulant Conley CL Harman RC. A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythymatosus. J Clin Invest 1952; 31: Lechner K Acquired inhibitors in auto and isoimmune diseases. Hemostasis 1974; 3:65-69 Feinstein DI, Rappaport SI. Acquired inhibitors of blood coagulation In Sapet TN, Eds; Progress in Hemostasis and Thrombosis, 1rst ed. Grune and Stratton New York, NY: 1982;6: Hassouna February 2,
3 APS is considered a hemorrhagic disease 1963 is linked to thrombosis LA is identified Circulating anticoagulants in SLE are named lupus anticoagulants ( LA) because they prolong the clotting times in phospholipid dependent assays. LA believed to cause clinical hemorrhagic disease 1963 LA are reported by Bowie et al to be associated with thrombosis in SLE patients LA are identified by Harris et al to be antibodies that react with cardiolipin Lupus anticoagulants react with purified cardiolipin and they are identified as anticardiolipin antibodies by RIA Hassouna February 2,
4 Lupus Anticoagulant believed to cause hemorrhagic disease. Also named circulating anticoagulant Lupus anticoagulant was applied to a clotting test that generates a prolonged clotting time in SLE patient plasma that did not correct when mixed in equal volume with pooled normal plasma. Hassouna February 2,
5 In 1963, Dr Bowie reported several cases of thrombosis in SLE despite circulating anticoagulants. This was the first report of an acquired thrombophilia. Thrombophilia is an inherited or acquired clinical phenotype that manifests in selected individuals as a greater risk to develop thrombosis in response to an ENDOGENOUS stimulus than the general population Bowie EJW, Thompson JH,, Pascuzzi CA, Owen CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: Hassouna February 2,
6 Hassouna February 2,
7 Gala dinner Penner Blood Coagulation Conference held in honor of Walter Bowie Hassouna February 2,
8 Hassouna February 2,
9 Lupus anticoagulant identified in 1983 by the anticardiolipin test to belong to the family of antiphospholipid antibodies Introduction of the anticardiolipin test identified the lupus anticoagulant as auto-antibodies directed at cardiolipin, a phospholipid in inner mitochondrial membranes Harris EN, Gharavi AE, Boey ML. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: Hassouna February 2,
10 Two mechanisms are identified in the induction of autoimmune Antiphospholipid antibodies (a PL) Apoptotic phospholipid protein complexes generate antibodies a PL From experiments in mice, a PL are produced by binding of beta2- glycoprotein 1 to phospholipid viral or bacterial proteins by molecular mimicry Hassouna February 2,
11 Cardiolipin is a phospholipid on the inner membrane of mitochondria first identified in bovine heart. Anticardiolipin antibodies ( lupus anticoagulant) represent an autoimmune process Hassouna February 2,
12 Autoimmune a PL are generated by apoptotic phospholipid protein complexes in mitochondria and other cellular components Increased apoptosis as observed in blood of SLE patients, followed by enhanced phosphatidyl serine exposure provides molecular signal to macrophages and other antigen presenting cells leading to a PL Hassouna February 2,
13 Antiphospholipid antibodies are a heterogeneous group with a variety of target antigens. The most significant target antigen is the B2-glycoprotein 1 In 1990 Monica Galli and her group in Bergamo, Italy reported that the true antigenic targets of antiphospholipid antibodies are not the phospholipids but plasma proteins bound to an anionic surface. Galli M,Comfurius P, Massen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein co-factor. Lancet 1990;334: Hassouna February 2,
14 Reproduced with permission Chethan Puttarajappa, MD review article submitted in fulfillment for the thrombosis rotation requirement beta-2-glycoprotein 1 is the most common and best-characterized antigenic target of auto-immune antiphospholipid antibodies. Beta-2 glycoprotein 1, also known as apolipoprotein H is an anticoagulant plasma protein belonging to the complement control protein family, and it is present in plasma at a concentration of approximately micrograms per milliliter. Beta-2 glycoprotein 1 anticoagulant action is by interaction with anionic phospholipids via a lysine rich region in the extra 20 amino acid C-terminal loop of the fifth domain that prevents thrombin amplification by the prothrombinase activity and prevents ADP induced platelet aggregation Hassouna February 2,
15 . Domain specificity of anti-β 2 -GPI antibodies as suggested by different research groups. Schematic picture of β 2 -GPI with the five domains (A) and crystal structure of β 2 -GPI (B) [18]. Hassouna February 2,
16 Induction of experimental a PL in naive mice: β2gpi epitope mimicry with bacterial particles. Hassouna February 2,
17 Molecular mimicry between β2gpi and common bacteria/viruses. The sequence similarity of these proteins to the domain 5 phospholipid binding region of beta2-glycoprotien 1 breaks the tolerance to self beta2-glycoprotein 1 and induces antibodies against t he beta2-glycoprotein 1 lysine rich phospholipid binding region CLOSE Hassouna February 2,
18 Interaction of β 2 -GPI with ApoER2 receptor on platelets. After dimerization by anti-β 2 -GPI autoantibodies subsequently, β 2 -GPI can bind to anionic phospholipids on the membrane of the platelet. β 2 -GPI binds to the ApoER2 receptor. This reaction results in the release of thromboxane A2. Hassouna February 2,
19 In 1984, a group of rheumatologists led by Graham Hughes found that in their sizeable collection of SLE patients the Lupus anticoagulant occurred with some frequency and was associated with thrombosis and thrombocytopenia and this raised the possibility that patients with the lupus anticoagulant and anti-cardiolipin antibodies might be a part of a larger body of patients with systemic auto-immune diseases Hassouna February 2,
20 Patients with LA are part of a larger body of patients with systemic autoimmune diseases conditions caused by the breakdown of immune tolerance and resultant immune responses to self-antigens. Auto-reactive CD4+ and CD8+ T cells t induce tissue damage in patients with various autoimmune diseases, including immune thrombocytopenic purpura, antiphospholipid syndrome, and myasthenia gravis. Hassouna February 2,
21 who symptoms conferences membership newswe are what diagnosis publications fundraising events we do treatment patient shop research FAQs research activities publicity prognosis Hassouna February 2,
22 Catastrophic APS Asherson Syndrome Lupus anticoagulant discriminates from DIC and TTP There is a small group of APS patients who present with occlusive events at multiple sites over a short period of time resulting in multi organ failure. The majority of catastrophic episodes are preceded by a precipitating events mainly infections Less than 1% of APS patients Hassouna February 2,
23 Antiphospholipid Syndrome has 3 components: Lupus anticoagulant is a term applied to a prolonged clotting time in a phospholipid dependent clotting test Antiphospholipid antibodies is a general term applied to antibodies generated by an autoimmune or an infectious process An acquired thrombophilia ( arterial and venous thrombosis, recurrent pregnancy loss, thrombocytopenia) caused by autoimmune or infectious processes that generate antibodies harmful to endothelium and platelets. Hassouna February 2,
24 Antiphospholipid Syndrome Clinical Phenotype Arterial and venous Thrombosis Obstetric complications Recurrent miscarriages Pre-eclampsia Intrauterine growth retardation Thrombocytopenia Hassouna February 2,
25 Significance of the Lupus anticoagulant in the diagnosis of APS Hassouna February 2,
26 Lupus Anticoagulant Lupus anticoagulant is a term applied to a clotting test that generates a prolonged clotting time in the patient s plasma that does not correct when mixed in equal volume with pooled normal plasma. Hassouna February 2,
27 Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the APS syndrome: a systemic review of the literature. Monica Galli, David Luciani, et al Blood 2003;101: Hassouna February 2,
28 Litterature search stategy on the association between a PL and thrombosis. Study desigh chort prospective, cross sectional, case control, ambispective, retrospective. Galli, M. et al. Blood 2003;101: Copyright 2003 American Society of Hematology. Copyright restrictions may apply. Hassouna February 2,
29 Studies on lupus anticoagulants and anticardiolipin antibodies Figure 2 All studies reported a significant 95% CI between lupus anticoagulants and, and thrombosis and the odds ratio ranged from 5-71 to 9.4 Hassouna February 2,
30 Figure 3. Galli, M. et al. Blood 2003;101: Copyright 2003 American Society of Hematology. Copyright restrictions may apply. Hassouna February 2,
31 Figure 6. Galli, M. et al. Blood 2003;101: Copyright 2003 American Society of Hematology. Copyright restrictions may apply. Hassouna February 2,
32 Table 1.. Strength of the association between lupus anticoagulants, anticardiolipin antibodies, and thrombosis Type of thrombosis Lupus anticoagulan ts * Odds ratio range Anticardioli pin antibodies * Odds ratio range Arterial 2/ /19 NS-18 Venous 5/ /12 NS-2.51 Any 2/ /2 NS-3.66 Hassouna February 2,
33 Clinical Utility of Laboratory tests used to identify APS antibodies and to diagnose the APS Galli M Semin Thromb Hemost 2008; 34: Lupus Anticoagulant is essentially a measure of the functional activity of subgroups of a PL directed against beta2-glycoproein 1 Hassouna February 2,
34 Fig. 1. Testing algorithm for clinical features suggesting antiphospholipid syndrome (APS). Reprinted from J Autoimmunity 2000; 15(2): Used with permission. β 2 GPI: β 2 glycorpotein I, ELISA: enzyme-linked immunosorbent assay. Hassouna February 2,
35 CLOSE Hassouna February 2,
36 Special Coagulation Laboratory Recipe for APS diagnosis APTT clotting times must be prolonged at least one and half times control plasma clotting times APTT prolonged clotting times does not correct in mixing patient plasma with pooled normal plasma ELISA identifies beta2-glycoprotein 1 antibodies. Testing is repeated when necessary. APS induced by viral or bacterial proteins disappears after infection is cured Hassouna February 2,
37 Hassouna February 2,
38 Hassouna February 2,
39 Question 1 A 57 years old female with lupus erythematosus presents with a deep venous obstruction of the left calf confirmed by Doppler ultrasound. Which of the following indicates a result positive for the APS. 1) Prothrombin time ( PT) 11.4 sec. Activated Partial Thromboplastin time ( APTT) 26.4 sec within normal range. Positive anticardiolipin antibodies. 2) PT 21 sec markedly prolonged. APTT 26.4 sec within normal range. Thrombin clotting time prolonged 16 sec (Control 8.2 sec). Thrombin clotted Fibrinogen 0.5 gram per liter (normal range 2-4 gram per liter). Immunoreactive fibrinogen 3 gram per Liter.( normal range 2-4 gram per liter) 3)PT 12.5 sec ( within normal range) APTT 48 sec ( prolonged) APTT does not correct in mixing studies. Negative anti-cardiolipin, anti-phospholipid, and beta-2- glycoprotein-1 antibodies. 4) PT 12.5 sec ( within normal range) APTT 48 sec ( prolonged) APTT does not correct in mixing studies. Positive anti-beta-2-glycoprotein-1 antibodies. Hassouna February 2,
40 Question 2 A 57 years old female with lupus erythematosus and a deep venous obstruction of the left calf confirmed by Doppler ultrasound, she tested positive for the antiphospholipid syndrome and was managed by conventional anticoagulation. After 6 months, results of a repeat Doppler ultrasound indicate complete resolution of the venous obstruction. One of the following is the correct choice for long term management: 1) Test for inherited thrombophilia to determine if patient remains on lifelong oral anticoagulation. 2) Antiphospholipid syndrome is an inherited thrombophilia requiring life long oral anticoagulation 3) Lifelong anticoagulation is indicated because thrombosis risk is extremely high (DVT, age, 4) antiphospholipid syndrome, lupus erythymatosus) 5) Complete resolution of venous obstruction indicates adequate hemostasis. Stop oral anticoagulation. Hassouna February 2,
41 Question 3 Chose the correct causative mechanism for arterial and venous thrombosis and repeated fetal loss in the antiphospholipid syndrome 1)Activation of clotting factor XI by antiphospholipid antibodies 2) The lupus anticoagulant damages the venous and arterial endothelium by complement activation 3) anti-beta 2 glycoprotein 1 antibodies bind antithrombin and markedly decrease natural anticoagulant plasma levels 4) Autoimmune antiphospholipid antibodies act by either one or by all the following mechanisms a) activation of complement, b) induction of tissue factor expression and cell adhesion receptors on endothelial cells c) promoting platelet aggregation, Hassouna February 2,
Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria
Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Farjah H AlGahtani Associate professor,md,mph Leukemia,Lymphoma in adolescent,thromboembolic
More informationThe Antiphospholipid Syndrome
The Antiphospholipid Syndrome 1 / 6 2 / 6 3 / 6 The Antiphospholipid Syndrome Antiphospholipid antibody syndrome (commonly called antiphospholipid syndrome or APS) is an autoimmune disease present mostly
More informationMohammadreza Tabatabaei IBTO COAG LAB
Tests for the Evaluation of Lupus Anticoagulants t Mohammadreza Tabatabaei MSc Hematology blood bank MSc Hematology blood bank IBTO COAG LAB Lupus Anticoagulants General Background Lupus anticoagulants
More informationDiagnosis of hypercoagulability is by. Molecular markers
Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna
More informationThrombophilia. Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS
Autoimmune Thrombophilia Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS Saraf@sina.tums.ac.ir Acquired Thrombophilia HIT PNH Cyckle cell Anemia Myeloproliferative lf Diseases Thrombocytosis
More informationLupus Anticoagulants (LA), Antiphospholipid (APL) Antibodies & APL Syndrome: Review & Update. Antiphospholipid. Antiphospholipid
, Antiphospholipid (APL) Antibodies & APL Syndrome: Review & Update William L. Nichols, MD Mayo Clinic College of Medicine Rochester, Minnesota USA Disclosures & Objectives (Nichols) Disclosures Relevant
More informationTHROMBOPHILIA SCREENING
THROMBOPHILIA SCREENING Introduction The regulation of haemostasis Normally, when a clot occurs, it exactly occurs where it has to be and does not grow more than necessary due to the action of the haemostasis
More informationAnti β 2. -Glycoprotein I and Antiphosphatidylserine Antibodies Are Predictors of Arterial Thrombosis in Patients With Antiphospholipid Syndrome
Coagulation and Transfusion Medicine / PREDICTIVE VALUE OF ANTIPHOSPHOLIPID ANTIBODIES Anti β -Glycoprotein I and Antiphosphatidylserine Antibodies Are Predictors of Arterial Thrombosis in Patients With
More informationKey words: antiphospholipid syndrome, trombosis, pathogenesis
26. XI,. 4/2011,.,..,..,., -..,,. 2GPI. -,.,,., -,, -, -,,,,, IL-1, IL-2, IL-6, IL-8, IL-12, IL-10, TNF, INF-. :,, N. Stoilov, R. Rashkov and R. Stoilov. ANTIPHOSPHOLIPID SYNDROME HISTORICAL DATA, ETI-
More informationAntiphospholipid Syndrome
Antiphospholipid Syndrome EliA Cardiolipin and EliA β2-glycoprotein I Fully Automated Testing for Antiphospholipid Syndrome (APS) Testing for APS according to classification criteria determination of anti-β2-glycoprotein
More informationThrombophilia: To test or not to test
Kenneth Bauer, MD Harvard Medical School, Boston, MA Professor of Medicine VA Boston Healthcare System Chief, Hematology Section Beth Israel Deaconess Medical Center, Boston, MA Director, Thrombosis Clinical
More informationThrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI
Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri
More informationTECHNICAL SERIES. Lupus Anticoagulants: Basic Concepts and Laboratory Diagnosiss. ...Setting trends TULIP DIAGNOSTICS (P) LTD.
For the use of Registered Medical Practioners and Laboratories only TECHNICAL SERIES Lupus Anticoagulants: Basic Concepts and Laboratory Diagnosiss TULIP DIAGNOSTICS (P) LTD. Gitanjali, Tulip Block, Dr.
More informationEDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION
EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationApproach to Thrombosis
Approach to Thrombosis Theera Ruchutrakool, M.D. Division of Hematology Department of Medicine Siriraj Hospital Faculty of Medicine Mahidol University Approach to Thrombosis Thrombosis: thrombus formation
More informationAre there still any valid indications for thrombophilia screening in DVT?
Carotid artery stenosis and risk of stroke Are there still any valid indications for thrombophilia screening in DVT? Armando Mansilha MD, PhD, FEBVS Faculty of Medicine of University of Porto Munich, 2016
More informationInherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD
Inherited Thrombophilia Testing George Rodgers, MD, PhD Kristi Smock MD Prevalence and risk associated with inherited thrombotic disorders Inherited Risk Factor % General Population % Patients w/ Thrombosis
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationCurrent View of the Treatment of Antiphospholipid Syndrome
GROUPE HOSPITALIER PITIE SALPETRIERE Current View of the Treatment of Antiphospholipid Syndrome Pr Zahir AMOURA Department of Internal Medicine French National Reference center for SLE and APS Hôpital
More informationT he antiphospholipid syndrome (APS) is a thrombophilic
1639 EXTENDED REPORT ntiphospholipid antibody tests: spreading the net M L ertolaccini, S Gomez, J F P Pareja, Theodoridou, G Sanna, G R V Hughes, M Khamashta... See end of article for authors affiliations...
More informationAN INTERESTING CASE OF RESPIRATORY DISTRESS. Dr.V.Akila Devi DNB PG Southern Railway Headquarters Hospital Chennai
AN INTERESTING CASE OF RESPIRATORY DISTRESS Dr.V.Akila Devi DNB PG Southern Railway Headquarters Hospital Chennai 11 month old female infant 1 st born to parents of NC marriage referred from Kolkatta H/O:
More informationPrimary Exam Physiology lecture 5. Haemostasis
Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation
More informationAntiphospholipid antibodies
CARDIOLOGY PATIENT PAGE CARDIOLOGY PATIENT PAGE Antiphospholipid Antibodies Caron P. Misita, PharmD; Stephan Moll, MD Antiphospholipid antibodies (APLAs) are proteins that may be present in the blood and
More informationThrombophilia. Stephan Moll, MD Medicine, Heme-Coag UNC Chapel Hill, NC. GASCO Atlanta Sept 8 th, Disclosures. Conflicts of interest: NONE
LA APLA 1 3 ACA Anti-ß2-GP I 2 45 Thrombophilia Stephan Moll, MD Medicine, Heme-Coag UNC Chapel Hill, NC GASCO Atlanta Sept 8 th, 2017 Disclosures Conflicts of interest: NONE Off-label product use discussion:
More informationSummary of the 11th International Congress on Antiphospholipid Antibodies, Sydney, Australia, November 2004
Journal of Reproductive Immunology 66 (2005) 85 90 Meeting report Summary of the 11th International Congress on Antiphospholipid Antibodies, Sydney, Australia, November 2004 The 11th International Congress
More informationThursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III
REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels
More informationDISCLOSURE. Presented by: Merav Sendowski, MD Oregon Health and Science University
Thrombophilia! DISCLOSURE Presented by: Merav Sendowski, MD Oregon Health and Science University Created by: Thomas Deloughery, MD Oregon Health and Science University Current Relevant Financial Relationship(s)
More information10/24/2013. Heparin-Induced Thrombocytopenia (HIT) Anticoagulation Management in ECMO Therapy:
Anticoagulation Management in ECMO Therapy: Heparin-Induced (HIT) Michael H. Creer, MD Professor of Pathology Director, Clinical Laboratories, Medical Co- Director, Hematopathology and Chief, Division
More informationAntiphospholipid antibodies are a heterogeneous family
Seasonal Distribution of Antiphospholipid Antibodies Thanh-Ha Luong, MD; Jacob H. Rand, MD; Xiao-Xuan Wu, MD; James H. Godbold, PhD; Mayra Gascon-Lema, MS; Stanley Tuhrim, MD Background and Purpose The
More informationHaemostasis & Coagulation disorders Objectives:
Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?
More informationOptimal Utilization of Thrombophilia Testing
Optimal Utilization of Thrombophilia Testing Rajiv K. Pruthi, MBBS Special Coagulation Laboratory & Comprehensive Hemophilia Center Division of Hematology/Internal Medicine Dept of Laboratory Medicine
More informationå ORIGINAL ARTICLE å Distribution and Clinical Significance of Lupus Anticoagulant and Anticardiolipin Antibody in 349 Patients with
å ORIGINAL ARTICLE å Distribution and Clinical Significance of Lupus Anticoagulant and Anticardiolipin Antibody in 349 Patients with Systemic Lupus Erythematosus Chiho Ninomiya, Osamu Taniguchi, Toshihiko
More informationAntiphospholipid Antibody Syndrome: Management Issues for the Hematologist
Antiphospholipid Antibody Syndrome: Management Issues for the Hematologist Wisconsin Institute of Discovery Karen Rossi/Bristol-Myers Squibb Morey A. Blinder, MD Washington University, St. Louis, MO March
More informationConsultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000
Consultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000 Dorothy M. (Adcock) Funk, M.D. Karen A. Moser, M.D. Esoterix Coagulation September 20, 2013 Disclosures
More informationWarfarin Does Not Interfere with Lupus Anticoagulant Detection by Dilute Russell s Viper Venom Time
Clin. Lab. 2009;55:XXX-XXX Copyright ORIGINAL ARTICLE Warfarin Does Not Interfere with Lupus Anticoagulant Detection by Dilute Russell s Viper Venom Time HORATIU OLTEANU 2, KATHARINE. A. DOWNES 1, JIGAR
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationSchematic Of Heparin Induced Thrombocytopenia Platelet Count
Schematic Of Heparin Induced Thrombocytopenia Platelet Count Normal IgG and IgG2 differentially inhibit HIT antibody-dependent platelet activation that platelet counts were lower in FcγRIIA 131RR patients
More informationEDUCATIONAL COMMENTARY PLATELET DISORDERS
EDUCATIONAL COMMENTARY PLATELET DISORDERS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn
More informationThyroid disease and haemostasis: a relationship with clinical implications? Squizzato, A.
UvA-DARE (Digital Academic Repository) Thyroid disease and haemostasis: a relationship with clinical implications? Squizzato, A. Link to publication Citation for published version (APA): Squizzato, A.
More informationLupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome
Turk J Hematol 2007; 24:69-74 Turkish Society of Hematology RESEARCH ARTICLE Lupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome Shveta Garg, Annamma
More informationAutoantibodies have been implicated in a variety of diseases.
Antiphospholipid Antibodies Douglas A. Triplett, MD Objective. To review the role of lupus anticoagulants in the pathogenesis of both venous and arterial thromboembolic events, as well as in recurrent
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationHemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures
Hemostasis PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures Disorders of Hemostasis - Hemophilia - von Willebrand Disease HEMOPHILIA A defect in the thrombin propagation phase
More informationDisseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.
Disseminated Intravascular Coagulation (DIC) Seminar Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.2012 1 Our plan: Understand the pathophysiology Identify risk factors
More informationTHROMBOSIS PRODUCT HIGHLIGHTS
PRODUCT HIGHLIGHTS AESKU.DIAGNOSTICS has extensive experience and know-how in the Anti-Phospholipid Syndrome (APS) field and offers the most comprehensive panel of anti-phospholipid tests, employing highly
More informationPCCN Review Hematology
PCCN Review Hematology Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Anemia Definition reduction in RBC concentration Causes iron deficiency
More informationTHROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO
THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO DISCLAIMER I m a pediatrician I will be discussing this issue primarily from a pediatric perspective
More informationCoagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University
In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets
More informationAntiphospholipid Syndrome Handbook
Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, Oier Ateka-Barrutia, and Munther A. Khamashta Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, MD, PhD Lupus Research Unit The Rayne
More informationAntiphospholipid antibodies in patients with venous thrombosis at Kenyatta National Hospital
Research article Department of Human Pathology, School of Medicine, University of Nairobi, P. O. Box 19676 00202, Nairobi, Kenya Corresponding author: Dr KA Barasa, Department of Human Pathology, School
More informationBleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph
Bleeding Disorders Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Normal hemostasis The normal hemostatic response involves interactions among: The blood vessel wall (endothelium)
More informationCOAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)
COAGULATIONS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin) Haemostasis-blood must be maintained in a fluid state in order to function as a transport system, but must be able to solidify to form a clot following
More informationAnaesthesiologic management of a parturient with a known antiphospholipid syndrome
Anaesthesiologic management of a parturient with a known antiphospholipid syndrome Pascal Vuilleumier Universitätsklinik für Anästhesie und Schmerztherapie Case presentation: Mrs A. B. 1975 Early monday
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Phospholipids as a Predisposing Factor of Recurrent Miscarriage in Sudanese Women Jevara Mohamed
More informationGenerate Knowledge Lupus Anticoagulant Testing Made Simple
Generate Knowledge Lupus Anticoagulant Testing Made Simple Paul Riley, PhD, MBA Learning objectives Describe antiphospholipid syndrome (aps) and role of the lupus anticoagulant (LA) in thrombosis Present
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
١ Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationMost Common Hemostasis Consults: Thrombocytopenia
Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial
More informationDisseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department
Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC, consumptive coagulopathy) is a clinicopathologic
More informationDOWNLOAD OR READ : POSITIVE OPTIONS FOR ANTIPHOSPHOLIPID SYNDROME APS SELF HELP AND TREATMENT PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : POSITIVE OPTIONS FOR ANTIPHOSPHOLIPID SYNDROME APS SELF HELP AND TREATMENT PDF EBOOK EPUB MOBI Page 1 Page 2 positive options for antiphospholipid syndrome aps self help and treatment
More informationThrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13
Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Mark Cunningham,MD Director, Hematology Laboratory Department of Pathology University of Kansas Medical Center College of American Pathologists
More informationChapter 19. Hemostasis
Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationCOAGULATION INHIBITORS LABORATORY DIAGNOSIS OF PROTHROMBOTIC STATES REGULATION OF. ANTICOAGULANT PROTEIN DEFICIENCY Disease entities COAGULATION
LABORATORY DIAGNOSIS OF PROTHROMBOTIC COAGULATION INHIBITORS Tissue Factor Pathway Inhibitor (TFPI) Lipoprotein Associated Coagulation Inhibitor (LACI) Extrinsic Pathway Inhibitor (EPI) Complexes with
More informationPrevalence of antiphospholipid auto antibodies in patients with thrombosis
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 6/ September 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Prevalence of antiphospholipid auto antibodies in patients
More informationAntiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis?
Rheum Dis Clin N Am 32 (2006) 455 463 Antiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis? Maria Laura Bertolaccini, MD, PhD*, Graham R.V. Hughes, MD, FRCP Lupus Research Unit, The Rayne
More informationLaboratory Evaluation of Venous Thrombosis Risk
Laboratory Evaluation of Venous Thrombosis Risk Dorothy M. Adcock, MD Volume 17, Number 12 December 2003 Objective: The reader will be able to discuss the concepts of risk factor, risk potential and thrombotic
More informationTopics of today lectures: Hemostasis
Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood
More informationThis slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion
This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms
More informationRecommendations for Celiac Disease Testing. IgA & ttg IgA
Recommendations for Celiac Disease Testing IgA & ttg IgA IgA Normal ttg IgA Negative IgA >10 mg/dl, but less than age matched range IgA
More informationCase Report Lower Limb Ischemia: Aortoiliac Thrombosis Related to Antiphospholipid Syndrome (APS) Case Report and Review of the Literature
Case Reports in Surgery Volume 2013, Article ID 536971, 4 pages http://dx.doi.org/10.1155/2013/536971 Case Report Lower Limb Ischemia: Aortoiliac Thrombosis Related to Antiphospholipid Syndrome (APS) Case
More informationSang Hyuk Park, 1,2 Seongsoo Jang, 3 Chan-Jeoung Park, 3 and Hyun-Sook Chi Introduction
BioMed Research International Volume 2016, Article ID 2641526, 6 pages http://dx.doi.org/10.1155/2016/2641526 Research Article Clinical Application of Revised Laboratory Classification Criteria for Antiphospholipid
More informationA Case of Factor XII Deficiency Which was Found in Recurrent Spontaneous Abortion. Y. S. Nam, I. H. Kim, T. K. Yoon, C. N. Lee and K. Y.
12 1 A Case of Factor XII Deficiency Which was Found in Recurrent Spontaneous Abortion Y S Nam, I H Kim, T K Yoon, C N Lee and K Y Cha Department of Obstetrics and Gynecology, College of Medicine, Pocheon
More informationDisseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS
به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation
More informationTesting strategies for diagnosing lupus anticoagulant: decision analysis Segal J B, Lehmann H P, Petri M, Mueller L, Kickler T S
Testing strategies for diagnosing lupus anticoagulant: decision analysis Segal J B, Lehmann H P, Petri M, Mueller L, Kickler T S Record Status This is a critical abstract of an economic evaluation that
More informationThrombosis. By Dr. Sara Mohamed Abuelgasim
Thrombosis By Dr. Sara Mohamed Abuelgasim 1 Thrombosis Unchecked, blood coagulation would lead to dangerous occlusion of blood vessels if the protective mechanisms of coagulation factor inhibitors, blood
More informationORIGINAL PAPERS. Marek Cieśla 1, B D, Ewa Wypasek 1, 2, B D 1, 2, A, E, F. Abstract
ORIGINAL PAPERS Adv Clin Exp Med 2014, 23, 5, 729 733 ISSN 1899 5276 Copyright by Wroclaw Medical University Marek Cieśla 1, B D, Ewa Wypasek 1, 2, B D 1, 2, A, E, F, Anetta Undas IgA Antiphospholipid
More informationChoosing Wisely: If, When, What, and Who to Test for Thrombophilia
Choosing Wisely: If, When, What, and Who to Test for Thrombophilia Nicole Dodge Zantek, MD, PhD Medical Director, Special Coagulation Laboratory University of Minnesota Disclosures Financial interests
More informationDOACs in SPECIAL POPULATIONS
DOACs in SPECIAL POPULATIONS Ann K Wittkowsky PharmD, CACP, FASHP, FCCP Clinical Professor University of Washington School of Pharmacy Director, Anticoagulation Services UWMedicine Department of Pharmacy
More informationAPPENDIX 1 Eight New Cases of LAHS and Review of the Literature: Clinical and Laboratory Data
Supplementary Digital Content 1 Mazodier et al. Lupus Anticoagulant- Hypoprothrombinemia Syndrome: Report of 8 Cases and Review of the Literature Medicine (Baltimore). 2012;91(5). APPEDIX 1 Eight ew Cases
More informationAnticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT
Haemostasis Thrombosis Phases Endogenous anticoagulants Stopping blood loss Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT Vascular Platelet
More informationPathology note 8 BLEEDING DISORDER
Pathology note 8 BLEEDING DISORDER Slide75 ( Types of clotting factors deficiency): Today we will talk about public public factor deficiency it could be acquired or inherited, acquired diseases are more
More informationChapter 19 Cardiovascular System Blood: Functions. Plasma
Chapter 19 Cardiovascular System Blood: Functions 19-1 Plasma Liquid part of blood. Colloid: liquid containing suspended substances that don t settle out of solution 91% water. Remainder proteins, ions,
More informationInteractive Case Vignette: DOACs (Direct Oral Anti-Coagulants) vs. Warfarin for APLA (Anti-Phospholipid Antibody Syndrome)
Interactive Case Vignette: DOACs (Direct Oral Anti-Coagulants) vs. Warfarin for APLA (Anti-Phospholipid Antibody Syndrome) Ara Metjian, MD Duke Debates Benign Hematologic Highlights April 22, 2017 Disclaimer
More informationDaniel Egan, MD April 13, 2012
Daniel Egan, MD April 13, 2012 Aug 2006 (at age 15): Acute unprovoked DVT in left common femoral vein Factor V Leiden heterozygous Positive lupus inhibitor Lovenox BID 2 weeks later: increased clot burden,
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More informationCh. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma
Chapt. 45 Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma Inheritance of X-linked gene for Factor VIII hemophilia A Explain the
More informationDISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital
DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital Disseminated intravascular coagulation (DIC) Disseminated
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationHEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS
1 of 6 Policy #: 800 (PLH-800-13) Initiated Date: 12/4/2002 Reviewed Date: 8/1/2016 Subject: HEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS Approved by: Laboratory Director, Jerry Barker (electronic signature)
More informationPathophysiology. Tutorial 3 Hemodynamic Disorders
Pathophysiology Tutorial 3 Hemodynamic Disorders ILOs Recall different causes of thrombosis. Explain different types of embolism and their predisposing factors. Differentiate between hemorrhage types.
More informationEpidemiologia e clinica del tromboembolismo venoso. Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione
Epidemiologia e clinica del tromboembolismo venoso Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione Thrombophilia may present clinically as one or more of several thrombotic manifestations
More informationManaging Coagulopathy in Intensive Care Setting
Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury
More informationFaculty Disclosure. Hypercoagulable States. Learning Objectives. Hereditary Thombophilia. Acquired Hypercoagulable States 5/9/2016
Faculty Disclosure Hypercoagulable States Dr. Rizal has no actual or potential conflict of interest associated with this presentation By: Dr. Anuja Rizal Pharm. D., RPh., CACP Clinical Coordinator UConn
More informationINHERITED COAGULOPATHY
Disorder Etiology Pathophysiology and Presentation Lab Findings and Diagnosis Treatment INHERITED COAGULOPATHY HEMOPHILIA A and B Hemophilia A: deficiency in XIII (85%) Hemophilia B: deficiency in IX (15%)
More informationMoath Darweesh. Omar Sami. Saleem Khreisha. 1 P a g e
7 Moath Darweesh Omar Sami Saleem Khreisha 1 P a g e -First of all, I want to give a quick revision to simplify the whole hemostasis mechanism, it will be much easier here with me. Enjoy (you can skip
More informationKeywords: APA, ACA, ANA, Anti-dsDNA, RM, LA, APTT, PT.
bü z ÇtÄ TÜà väx Determination of antiphospholipid antibodies and Thrombophilia in women with recurrent miscarriage Ahmed Bolad 1 *, Tagwa Yousif 1, Atif Elagib 2 ABSTRACT Background: Recurrent miscarriage
More informationCLINICAL FELLOWSHIP PROGRAM IN COAGULATION
CLINICAL FELLOWSHIP PROGRAM IN COAGULATION The Department of Pathology and Laboratory Medicine University of Alberta, Faculty of Medicine and Dentistry and Alberta Health Services CLINICAL FELLOWSHIP IN
More informationAnticardiolipin Antibodies in Patients With Type 2 Diabetes Mellitus
CM&R Rapid Release. Published online ahead of print February 26, 2009 as doi:10.3121/cmr.2008.828 Original Research Anticardiolipin Antibodies in Patients With Type 2 Diabetes Mellitus José María Calvo-Romero,
More informationPhysiology of. The Blood hemostasis. By prof. Israa f. jaafar
Physiology of The Blood hemostasis By prof. Israa f. jaafar Learning objectives Understand the Platelet structure and function Explane the Platelet production Understand the phases of hemostasis: vascular
More information